GERMETFMG Treatments Testing and Advancements ETF(Exchange Traded Fund )
XTF Rating* NR
Price:$34.00 0.9552(2.89%)
52 Week:$25.15 - $35.15
Volume: 33,048
Avg Daily Volume: 176,916
Market Cap: $76,003,040 Avg Trade Size: 99 shares
Fund Turnover: 14 days 8/5/2020 9:53:53 AM

ETFMG Treatments Testing and Advancements ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Treatments, Testing and Advancements Index

Inception Date: 6/17/2020Geography: US  Asset Class: Equity
Primary Exchange: NYSE ArcaInvestment Philosophy: Passively ManagedCapitalization: Broad/Multi Cap
Issuer: ETF Managers Capital LLCUnderlying Index: Prime Treatments, Testing and Advancements IndexSector: Healthcare > Pharmaceuticals
Index Provider: Prime IndexesIndex Composition: Cap-Weighted

Structural Integrity
Investment Metrics
Fund Holdings
Fund Exposure
News Headlines
Structural Integrity Metrics
as of 6/30/2020 Value  Rank (%)
Expense Ratio 0.68% 
Average Bid Ask Ratio Premium Content 
Tracking Error Premium Content 
Concentration Risk Premium Content 
Market Impact Premium Content 
Efficiency Premium Content 
Cap Gains Dist Premium Content 
as of 8/4/2020  
Avg Number of Components   (range) 57   (57-57)
Legal Structure Open-End Investment Company 
Annual Yield / SEC Yield 0.00% / -0.38%
Last Dividend PaidDate 0.0, n/a   See Distributions
Options / Futures Available N  /  N 
Short Interest / Days to Cover 0.4% /  0 days
Net Asset Value $76,023,740 
Premium (Discount) -0.03% 
*The XTF Rating for an ETF is based on statistical analysis of its structural integrity and investment metric giving a total range between 0 and 10 with 10 being the best. Read More.

© LSEG Information Services (US) Inc., All Rights Reserved. Disclaimer. Terms of Use. Privacy Policy. Cookie Policy. .10